ORAI1 channel gating and selectivity is differentially altered by natural mutations in the first or third transmembrane domain

M. Bulla,Gergely Gyimesi,J-H Kim,Rajesh Bhardwaj,M. Hediger,M. Frieden,N. Demaurex

Published 2018 in Journal of Physiology

ABSTRACT

Gain‐of‐function mutations in the highly selective Ca2+ channel ORAI1 cause tubular aggregate myopathy (TAM) characterized by muscular pain, weakness and cramping. TAM‐associated mutations in ORAI1 first and third transmembrane domain facilitate channel opening by STIM1, causing constitutive Ca2+ influx and increasing the currents evoked by Ca2+ store depletion. Mutation V107M additionally decreases the channel selectivity for Ca2+ ions and its inhibition by acidic pH, while mutation T184M does not alter the channel sensitivity to pH or to reactive oxygen species. The ORAI blocker GSK‐7975A prevents the constitutive activity of TAM‐associated channels and might be used in therapy for patients suffering from TAM.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-100 of 105 references · Page 1 of 2

CITED BY

Showing 1-42 of 42 citing papers · Page 1 of 1